ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?

Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute myocardial infarction are reviewed. The reasons of ambiguous results are discussed. A point of view that different ACE inhibitors may have the various efficacy and safety in patients with acute myocardi...

Full description

Bibliographic Details
Main Authors: S. Y. Martsevich, S. N. Tolpygina
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/462
_version_ 1826949826917433344
author S. Y. Martsevich
S. N. Tolpygina
author_facet S. Y. Martsevich
S. N. Tolpygina
author_sort S. Y. Martsevich
collection DOAJ
description Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute myocardial infarction are reviewed. The reasons of ambiguous results are discussed. A point of view that different ACE inhibitors may have the various efficacy and safety in patients with acute myocardial infarction is suggested.
first_indexed 2024-03-08T14:04:53Z
format Article
id doaj.art-4bcb3e039add4861b1221f8f0051cd18
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2025-02-17T22:20:50Z
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-4bcb3e039add4861b1221f8f0051cd182024-12-04T11:48:04ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0133687110.20996/1819-6446-2007-3-3-68-71462ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?S. Y. Martsevich0S. N. Tolpygina1State Research center of preventive medicine of Roszdrav, MoscowState Research center of preventive medicine of Roszdrav, MoscowData of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute myocardial infarction are reviewed. The reasons of ambiguous results are discussed. A point of view that different ACE inhibitors may have the various efficacy and safety in patients with acute myocardial infarction is suggested.https://www.rpcardio.online/jour/article/view/462myocardial infarctionangiotensin converting enzyme inhibitorsefficacysafety
spellingShingle S. Y. Martsevich
S. N. Tolpygina
ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
Рациональная фармакотерапия в кардиологии
myocardial infarction
angiotensin converting enzyme inhibitors
efficacy
safety
title ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
title_full ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
title_fullStr ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
title_full_unstemmed ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
title_short ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
title_sort angiotensin converting enzyme inhibitors in acute myocardial infarction when to start therapy and which drug to use
topic myocardial infarction
angiotensin converting enzyme inhibitors
efficacy
safety
url https://www.rpcardio.online/jour/article/view/462
work_keys_str_mv AT symartsevich angiotensinconvertingenzymeinhibitorsinacutemyocardialinfarctionwhentostarttherapyandwhichdrugtouse
AT sntolpygina angiotensinconvertingenzymeinhibitorsinacutemyocardialinfarctionwhentostarttherapyandwhichdrugtouse